Zoetis Inc. (NYSE:ZTS) Shares Sold by MainStreet Investment Advisors LLC

MainStreet Investment Advisors LLC trimmed its holdings in shares of Zoetis Inc. (NYSE:ZTS) by 6.3% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 20,309 shares of the company’s stock after selling 1,359 shares during the quarter. MainStreet Investment Advisors LLC’s holdings in Zoetis were worth $3,521,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Focus Financial Network Inc. ADV acquired a new stake in Zoetis in the 4th quarter worth approximately $2,159,000. Price T Rowe Associates Inc. MD lifted its stake in shares of Zoetis by 31.0% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 13,716,681 shares of the company’s stock worth $2,707,262,000 after buying an additional 3,244,074 shares during the period. Axiom Investors LLC DE grew its holdings in shares of Zoetis by 36.3% during the fourth quarter. Axiom Investors LLC DE now owns 594,474 shares of the company’s stock valued at $117,331,000 after buying an additional 158,459 shares during the last quarter. Global Assets Advisory LLC acquired a new position in shares of Zoetis in the 1st quarter valued at $8,831,000. Finally, Franklin Street Advisors Inc. NC raised its stake in Zoetis by 4.3% in the 1st quarter. Franklin Street Advisors Inc. NC now owns 121,024 shares of the company’s stock worth $20,478,000 after acquiring an additional 5,035 shares during the last quarter. 92.80% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research firms have weighed in on ZTS. Stifel Nicolaus reiterated a “buy” rating and set a $200.00 price target on shares of Zoetis in a research note on Tuesday, August 27th. Piper Sandler upped their target price on Zoetis from $195.00 to $210.00 and gave the company an “overweight” rating in a research report on Wednesday, August 14th. Argus raised shares of Zoetis to a “strong-buy” rating in a research report on Friday, August 9th. Finally, BTIG Research upped their price objective on shares of Zoetis from $220.00 to $225.00 and gave the company a “buy” rating in a report on Monday, August 12th. Nine equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, Zoetis currently has a consensus rating of “Buy” and an average price target of $217.11.

Zoetis Stock Up 1.4 %

ZTS stock opened at $189.23 on Friday. Zoetis Inc. has a one year low of $144.80 and a one year high of $201.92. The company has a debt-to-equity ratio of 1.32, a quick ratio of 2.09 and a current ratio of 3.45. The firm’s fifty day moving average is $181.22 and its 200 day moving average is $174.49. The firm has a market cap of $85.73 billion, a PE ratio of 36.46, a P/E/G ratio of 2.87 and a beta of 0.88.

Zoetis (NYSE:ZTS) last announced its quarterly earnings results on Tuesday, August 6th. The company reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.49 by $0.07. The firm had revenue of $2.36 billion during the quarter, compared to analyst estimates of $2.31 billion. Zoetis had a return on equity of 50.67% and a net margin of 26.29%. Zoetis’s revenue for the quarter was up 8.3% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.41 EPS. On average, research analysts forecast that Zoetis Inc. will post 5.84 EPS for the current year.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.